je.st
news
PBT2 Recommended For Orphan Designation In Europe
2015-04-29 03:49:41| drugdiscoveryonline Home Page
Prana Biotechnology is pleased to announce the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending designation of PBT2 for the treatment of Huntington disease as an orphan medicinal product to the European Commission (EC)
Tags: europe
recommended
designation
orphan
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||